Novartis $2 Million Gene Therapy for Rare Disorder is World’s Most Expensive Drug
Novartis has got the U.S. approval for Zolgensma drug for the treatment of spinal solid decay (SMA), the main hereditary ...
Tag: Novartis
FDA Approves Oral Drug Mayzent to Treat Multiple Sclerosis, Novartis
The U.S. Food and Drug Administration (FDA) has approved Mayzent tablets (siponimod) by Novartis for the treatment of Multiple Sclerosis ...
Egaten approved by FDA for the Treatment of ‘Fluke Infestation’
US FDA (Food and Drug Administration) has approved Egaten® (triclabendazole) for the treatment of fascioliasis. It can be used by ...
TRENDING THIS WEEK
© 2025 Higher Education Plus